StockNews.com Begins Coverage on Retractable Technologies (NYSE:RVP)

Equities researchers at StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a research note issued to investors on Monday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

NYSE:RVP opened at $0.91 on Monday. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01. The business’s 50-day simple moving average is $1.04 and its two-hundred day simple moving average is $1.09. The stock has a market cap of $27.25 million, a PE ratio of -3.50 and a beta of 2.08. Retractable Technologies has a 52 week low of $0.87 and a 52 week high of $1.34.

Retractable Technologies (NYSE:RVP) last posted its quarterly earnings results on Wednesday, August 14th. The company reported ($0.48) EPS for the quarter. The business had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.